The global “contract development and manufacturing organization market” size is projected to reach USD 278.98 billion by the end of 2026. Initially, Mergers and acquisitions are a growing trend among major companies across the world. According to a report published by Fortune Business Insights, titled “Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Industry Analysis, By Service {By CMO (API, Finished Product {Solid Dosage Forms, Injectables, and Others}, and Packaging)} {By CRO (Discovery, Preclinical, Clinical Trial, and Laboratory Services)} and Regional Forecast, 2019-2026,” the market was worth USD 130.80 billion in 2018 and will exhibit a CAGR of 10.0% during the forecast period, 2019-2026.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Report Overview:
The contract development and manufacturing organization market is segmented on the basis of factors such as service and geographies. So the report provides forecast values for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals. However, the report highlights the latest product launches and labels major innovations in the market. In addition to this, it states the impact of these products on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years.
Product Overview:
Contract development and manufacturing organization (CDMO) helps healthcare companies for the development of drugs. So it is involved in the overall process, right from the clinical trials till the commercialization and distribution of the drugs. The complexities in therapies and lack of in-house manufacturing capabilities will have a positive impact on the growth of the market in the coming years. But the high investment in CDMOs will bode well for the overall market in the coming years. Moreover, the increasing number of strategic mergers and collaborations will contribute to the growth of the market. So the use of advanced technologies in drug development processes will emerge in favor of the companies operating in the market.
However, COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. So the outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.
Please visit: https://www.fortunebusinessinsights.com/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502
Recipharm AB Introduces New Fully Integrated Service Platform
Accounting to the huge potential held by CDMOs, several companies are looking to invest more in the development of newer products. Therefore, huge investments have yielded a few exceptional products in recent years. In May 2019, Recipharm AB announced the launch of a fully integrated service platform for inhalation products. For instant, will include the early stages of the products including the pre-clinical trials to the commercialization of the products. Recipharm’s latest product will generate huge sales and subsequently high revenues for the company. And this will not just benefit the company, but will have a positive impact on the growth of the overall market in the coming years.
What does the Report Include?
The market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers the different regions, which are contributing to the growth of the market. On the other hand, it includes the competitive landscape that involves leading companies and adoption of strategies by them to introduce new products, announce partnerships, and collaborate that will contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.
What are the Objectives of the Report?
The report offers a comprehensive overview of the market and emphasizes on growth parameters such as drivers, restraints, challenges, and upcoming opportunities. It alsothrows light on the table of segmentation in detail and lists the names of the leading segments with market figures. The report also lists the names of significant players and the key strategies adopted by them to attain dominance in the market competition. Furthermore, the report discusses the major industry developments, current trends, and other useful facts that will help investors make strategic decisions and accordingly contribute to the market. For more information on the report, log on to the company website.
Asia Pacific to Register Highest CAGR; Increasing Company Collaborations Will Aid Growth of the Regional Market
Above all, the report analyses the ongoing CDMO market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Asia Pacific will register the highest CAGR in the coming years driven by the increasing number of company collaborations and mergers in several countries across the world. The market in North America is projected to emerge dominant in the coming years, owing to the presence of several well-established companies. As of 2018, the market in North America was worth USD 48.72 billion in 2018 and this value is projected to increase further in the coming years.
List of companies profiled in the report:
- Catalent, Inc
- Baxter
- Vetter
- Recipharm AB
- Albany Molecular Research Inc. (AMRI)
- Thermo Fisher Scientific Inc. (Patheon)
- Unither
- DPT LABORATORIES LTD.
- NextPharma Technologies
- Others
Industry Developments:
February 2019: So Jubilant Biosys collaborated with Sanofi to develop small molecule inhibitors for in the CNS therapeutic area.
Table Of Content
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Restraints
- Market Opportunities
- Key Insights
- Key Industry Developments (Mergers, Acquisitions, & Partnerships,)
- So the Regulatory Scenario for key countries/Regions
- Key Market Trends
- Key Services Mapping by Leading Players
- Global Contract Development and Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Service
- CMO
- API Manufacturing
- Finished Product Manufacturing
- Solid Dosage Forms
- Injectables
- Others (Semisolids/liquids, Powder)
- Packaging
- CRO
- Discovery
- Preclinical
- Clinical
- Laboratory Services
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
- CMO
